基于ERK-mTOR通路調(diào)控自噬探討六味地黃丸減輕成骨細(xì)胞氧化應(yīng)激損傷的分子機(jī)制_第1頁
基于ERK-mTOR通路調(diào)控自噬探討六味地黃丸減輕成骨細(xì)胞氧化應(yīng)激損傷的分子機(jī)制_第2頁
基于ERK-mTOR通路調(diào)控自噬探討六味地黃丸減輕成骨細(xì)胞氧化應(yīng)激損傷的分子機(jī)制_第3頁
基于ERK-mTOR通路調(diào)控自噬探討六味地黃丸減輕成骨細(xì)胞氧化應(yīng)激損傷的分子機(jī)制_第4頁
基于ERK-mTOR通路調(diào)控自噬探討六味地黃丸減輕成骨細(xì)胞氧化應(yīng)激損傷的分子機(jī)制_第5頁
已閱讀5頁,還剩3頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

基于ERK-mTOR通路調(diào)控自噬探討六味地黃丸減輕成骨細(xì)胞氧化應(yīng)激損傷的分子機(jī)制摘要:自噬是一種維持細(xì)胞穩(wěn)態(tài)的重要機(jī)制,而ERK/mTOR通路則是自噬的主要調(diào)節(jié)途徑之一。六味地黃丸是一種常用的中藥方劑,已被廣泛應(yīng)用于臨床治療骨質(zhì)疏松等疾病。本文旨在研究ERK/mTOR通路在六味地黃丸調(diào)控自噬中的作用,并探究六味地黃丸對成骨細(xì)胞氧化應(yīng)激損傷的分子機(jī)制。本研究使用成骨細(xì)胞進(jìn)行體外實(shí)驗(yàn),并使用Westernblot、免疫熒光等技術(shù)對細(xì)胞的生理指標(biāo)進(jìn)行分析。結(jié)果顯示,六味地黃丸可以通過抑制ERK/mTOR通路來促進(jìn)自噬的發(fā)生,并通過降低ROS水平來減輕成骨細(xì)胞氧化應(yīng)激損傷。該研究結(jié)果增加了對六味地黃丸調(diào)控自噬的認(rèn)識,為其在臨床應(yīng)用中提供了分子基礎(chǔ)。

關(guān)鍵詞:ERK/mTOR通路;自噬;六味地黃丸;成骨細(xì)胞;氧化應(yīng)激;ROS水平

Abstract:Autophagyisanimportantmechanismformaintainingcellularhomeostasis,andtheERK/mTORpathwayisoneofthemainregulatorypathwaysofautophagy.LiuweiDihuangWanisacommonlyusedtraditionalChinesemedicineformulaandhasbeenwidelyusedintheclinicaltreatmentofosteoporosisandotherdiseases.TheaimofthisstudywastoinvestigatetheroleoftheERK/mTORpathwayintheregulationofautophagybyLiuweiDihuangWanandtoexplorethemolecularmechanismofLiuweiDihuangWaninreducingoxidativestressdamageofosteoblasts.Invitroexperimentswereperformedusingosteoblasts,andthephysiologicalindicatorsofcellswereanalyzedusingWesternblot,immunofluorescence,andothertechniques.TheresultsshowedthatLiuweiDihuangWancanpromotetheoccurrenceofautophagybyinhibitingtheERK/mTORpathwayandreduceoxidativestressdamageofosteoblastsbyreducingtheROSlevel.ThisstudyincreasesourunderstandingoftheregulationofautophagybyLiuweiDihuangWanandprovidesamolecularbasisforitsclinicalapplication.

Keywords:ERK/mTORpathway;autophagy;LiuweiDihuangWan;osteoblast;oxidativestress;ROSleveLiuweiDihuangWanisawell-knowntraditionalChinesemedicinethathasbeenusedformanyyearsinthetreatmentofvariousdiseases,especiallythoserelatedtothekidneyandbone.However,itsmechanismofactionremainsunclear.Inthisstudy,weinvestigatedtheeffectofLiuweiDihuangWanonautophagyandoxidativestressinosteoblasts.

Autophagyisahighlyconservedcellularprocessthatplaysanimportantroleinmaintainingintracellularhomeostasisbyeliminatingdamagedorganellesandlargemolecularproteincomplexes.Ithasbeensuggestedthatautophagydysregulationmaycontributetothepathogenesisofvariousdiseases,includingbone-relateddiseases.Inthisstudy,wefoundthatLiuweiDihuangWancanpromoteautophagyinosteoblastsbyinhibitingtheERK/mTORpathway,whichisawell-knownnegativeregulatorofautophagy.OurresultsprovideanovelmechanismfortheregulationofautophagybyLiuweiDihuangWan.

Oxidativestress,whichisdefinedasanimbalancebetweentheproductionofreactiveoxygenspecies(ROS)andthecellularantioxidantdefensesystem,isknowntoplayacrucialroleinthedevelopmentofvariousdiseases,includingosteoporosis.Inthisstudy,wefoundthatLiuweiDihuangWancanreduceoxidativestressdamageinosteoblastsbyreducingtheROSlevel.OurresultsprovideanewinsightintothepotentialtherapeuticapplicationofLiuweiDihuangWaninthetreatmentofosteoporosis.

Inconclusion,ourstudyprovidesevidencethatLiuweiDihuangWancanpromoteautophagyandreduceoxidativestressdamageinosteoblastsbyregulatingtheERK/mTORpathwayandROSlevel,respectively.ThesefindingshighlightthepotentialofLiuweiDihuangWanasatherapeuticagentforthetreatmentofbone-relateddiseases,especiallyosteoporosis.FurtherstudiesareneededtoconfirmtheclinicalefficacyandsafetyofLiuweiDihuangWanasatreatmentforosteoporosisOsteoporosisisacommonskeletaldisorderthatischaracterizedbylowbonedensity,increasedbonefragility,andanincreasedriskoffractures.Itisamajorhealthproblemamongelderlypeopleworldwide,anditsprevalenceisexpectedtoriseinthecomingyearsduetoanagingpopulation.Osteoporosiscanseriouslyaffectthequalityoflifeofaffectedindividuals,anditisassociatedwithsignificanthealthcarecosts.

Thecurrenttreatmentsforosteoporosisincludelifestylemodifications,calciumandvitaminDsupplementation,anddrugtherapy.However,thesetherapieshavelimitations,andtheirefficacyandsafetyarenotalwayssatisfactory.Therefore,thereisaneedforthedevelopmentofnewandeffectivetreatmentsforosteoporosis.

TraditionalChinesemedicine(TCM)hasbeenusedforcenturiestotreatvariousdiseases,includingosteoporosis.LiuweiDihuangWanisaTCMformulathathasbeenusedtotonifythekidneyandnourishtheliverforthetreatmentofvariousailments,includingosteoporosis.Itiscomposedofsixherbalingredients,namely,Rehmanniaglutinosa,Cornusofficinalis,Dioscoreaopposita,Alismaorientale,Poriacocos,andPaeoniasuffruticosa.

Inrecentyears,studieshavesuggestedthatLiuweiDihuangWanmayhaveabeneficialeffectonbonehealth.Themechanismsunderlyingitseffectsonbonemetabolismarenotfullyunderstood,butrecentresearchhassuggestedthatLiuweiDihuangWanmaypromoteautophagyandreduceoxidativestressdamageinosteoblastsbyregulatingtheERK/mTORpathwayandROSlevel,respectively.

Autophagyisafundamentalcellularprocessthatplaysacriticalroleinmaintainingcellularhomeostasisbydegradingdamagedorganellesandproteins.Ithasbeensuggestedthatimpairedautophagyisinvolvedinthepathogenesisofosteoporosis.LiuweiDihuangWanhasbeenshowntopromoteautophagyinosteoblasts,whichmaycontributetoitsbeneficialeffectsonbonehealth.

Oxidativestressisaconditioninwhichthereisanimbalancebetweentheproductionofreactiveoxygenspecies(ROS)andtheabilityofcellstoneutralizethem.ROScancausedamagetocellsandtissues,andhavebeenimplicatedinthedevelopmentofvariousdiseases,includingosteoporosis.LiuweiDihuangWanhasbeenshowntoreduceoxidativestressdamageinosteoblasts,whichmaycontributetoitsbeneficialeffectsonbonehealth.

TheERK/mTORpathwayisasignalingpathwaythatplaysacriticalroleincellgrowthandsurvival.Dysregulationofthispathwayhasbeenimplicatedinthepathogenesisofvariousdiseases,includingosteoporosis.LiuweiDihuangWanhasbeenshowntoregulatetheERK/mTORpathwayinosteoblasts,whichmaycontributetoitsbeneficialeffectsonbonehealth.

Overall,theavailableevidencesuggeststhatLiuweiDihuangWanmayhaveabeneficialeffectonbonehealthbypromotingautophagyandreducingoxidativestressdamageinosteoblastsbyregulatingtheERK/mTORpathwayandROSlevel,respectively.FurtherstudiesareneededtoconfirmtheclinicalefficacyandsafetyofLiuweiDihuangWanasatreatmentforosteoporosis.Ifproveneffective,LiuweiDihuangWanmayprovideanalternativeorcomplementarytherapyforosteoporosispatientsAdditionally,LiuweiDihuangWanhasshownpotentialinimprovingcognitivefunctionandreducingoxidativestressinthebrain.Studieshavefoundthatitsactivecompounds,suchascatalpolandloganin,exhibitneuroprotectiveeffectsbymodulatingseveralsignalingpathwaysinvolvedinneuronalfunctionandsurvival.LiuweiDihuangWanhasalsobeenreportedtoenhancememoryandlearningabilityinanimalmodelsofAlzheimer'sdiseaseandage-relatedcognitivedecline.

Moreover,LiuweiDihuangWanhasbeenusedinTraditionalChineseMedicineforitsanti-inflammatoryandimmune-modulatingproperties.Ithasbeenfoundtoinhibittheproductionofinflammatorycytokinesandpromotetheactivityofimmunecells,suggestingitspotentialintreatingimmune-relateddisorderssuchasrheumatoidarthritisandlupus.

However,despitethesepotentialhealthbenefits,thereisaneedforfurtherstudiestoinvestigatethesafetyandefficacyofLiuweiDihuangWaninhumans.Adverseeffectsanddruginteractionsmayalsooccurwithprolongeduseorhighdosesoftheherbalmedicine.

Inconclusion,LiuweiDihuangWanisatraditionalChi

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

最新文檔

評論

0/150

提交評論